Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Klonaris

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Annals of Vascular Surgery|July 24, 2025
Polycystin-1 as a Novel Biomarker for Peripheral Artery Disease: Findings from a Pilot Prospective StudyP G Theodoridis, S Georgopoulos, C Bakoyiannis, et al.
Chemotherapy|May 1, 1996
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancerN Tsavaris, K Tentas, P Kosmidis, et al.
American Journal of Clinical Oncology|October 1, 1996
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trialN B Tsavaris, K Tentas, P Kosmidis, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Annals of Vascular Surgery|July 24, 2025
Polycystin-1 as a Novel Biomarker for Peripheral Artery Disease: Findings from a Pilot Prospective StudyP G Theodoridis, S Georgopoulos, C Bakoyiannis, et al.
Chemotherapy|May 1, 1996
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancerN Tsavaris, K Tentas, P Kosmidis, et al.
American Journal of Clinical Oncology|October 1, 1996
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trialN B Tsavaris, K Tentas, P Kosmidis, et al.
Pageof 3